Remove 2022 Remove Chronic pain management Remove Mental health Remove Remote care
article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

These multiples are down from the levels seen in 2022, but they are still higher than the average EV to sales multiple for all industries. The most active subsectors for DTx M&A deals are mental health, oncology, and diabetes. EV to EBITDA: 12.5x The average deal size for DTx M&A deals is increasing.